These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 31672255)
21. Bilateral adrenal gland hemorrhage in a patient treated with rivaroxaban. Comuth W; Christiansen JJ; Bloch-Münster AM; Husted S Blood Coagul Fibrinolysis; 2017 Jan; 28(1):102-104. PubMed ID: 26919451 [TBL] [Abstract][Full Text] [Related]
22. [Acute adrenal insufficiency during unilateral adrenal hemorrhage secondary to the antiphospholipid syndrome]. Blanc PL; Forel C; Jay S; Susset V Rev Med Interne; 2006 Dec; 27(12):970-2. PubMed ID: 16997432 [TBL] [Abstract][Full Text] [Related]
23. Bilateral Adrenal Hemorrhage in a Patient with Antiphospholipid Syndrome during Chronic Graft-versus-host Disease. Minami M; Muta T; Adachi M; Higuchi M; Aoki K; Ogawa R Intern Med; 2018 May; 57(10):1439-1444. PubMed ID: 29279512 [TBL] [Abstract][Full Text] [Related]
24. Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS). Woller SC; Stevens SM; Kaplan DA; Branch DW; Aston VT; Wilson EL; Gallo HM; Johnson EG; Rondina MT; Lloyd JF; Evans RS; Elliott CG Clin Appl Thromb Hemost; 2016 Apr; 22(3):239-47. PubMed ID: 26566669 [TBL] [Abstract][Full Text] [Related]
25. Adrenal crisis due to bilateral adrenal hemorrhage in primary antiphospholipid syndrome. Ringkananon U; Khovidhunkit W; Vongthavaravat V; Sridama V; Lalitanantpong S; Snabboon T J Med Assoc Thai; 2005 Apr; 88(4):534-7. PubMed ID: 16146261 [TBL] [Abstract][Full Text] [Related]
26. [Bilateral adrenal hemorrhage with adrenal insufficiency in the framework of primary antiphospholipid antibody syndrome]. Stricker H; Bertini F; Mombelli G Schweiz Med Wochenschr; 2000 Apr; 130(17):625-8. PubMed ID: 10829300 [TBL] [Abstract][Full Text] [Related]
27. Adrenal failure and the primary antiphospholipid syndrome. Walz B; Ho Ping Kong H; Silver R J Rheumatol; 1990 Jun; 17(6):836-7. PubMed ID: 2388207 [TBL] [Abstract][Full Text] [Related]
28. [Adrenal insufficiency and antiphospholipid syndrome]. Christofilis MA; Silvestre-Aillaud P; Piquet P; Aillaud MC; Vialettes B Ann Endocrinol (Paris); 1994; 55(6):283-7. PubMed ID: 7864586 [TBL] [Abstract][Full Text] [Related]
29. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis. Gómez-Outes A; Terleira-Fernández AI; Lecumberri R; Suárez-Gea ML; Vargas-Castrillón E Thromb Res; 2014 Oct; 134(4):774-82. PubMed ID: 25037495 [TBL] [Abstract][Full Text] [Related]
30. Safety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease. Sarratt SC; Nesbit R; Moye R Ann Pharmacother; 2017 Jun; 51(6):445-450. PubMed ID: 28478715 [TBL] [Abstract][Full Text] [Related]
31. [Proper use of apixaban: an outline for clinical practice]. Albaladejo P; Deplanque D; Fossati F; Mahagne MH; Mismetti P; Nguyen P; Roy P; Touze E; Mourad JJ J Mal Vasc; 2014 Dec; 39(6):409-25. PubMed ID: 25451020 [TBL] [Abstract][Full Text] [Related]
32. Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban. Stammler R; Legendre P; Cacoub P; Blanche P; Piette JC; Costedoat-Chalumeau N Lupus; 2020 Jun; 29(7):787-790. PubMed ID: 32223511 [TBL] [Abstract][Full Text] [Related]
33. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study). Nakamura M; Nishikawa M; Komuro I; Kitajima I; Uetsuka Y; Yamagami T; Minamiguchi H; Yoshimatsu R; Tanabe K; Matsuoka N; Kanmuri K; Ogawa H Circ J; 2015; 79(6):1230-6. PubMed ID: 25912695 [TBL] [Abstract][Full Text] [Related]
34. Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients. Christen JR; Bertolino J; Jean E; Camoin L; Ebbo M; Harlé JR; Schleinitz N; Sarlon G; Bernit E Hemoglobin; 2019; 43(4-5):296-299. PubMed ID: 31724442 [TBL] [Abstract][Full Text] [Related]
35. [Metastatic adrenal necrosis under sorafenib treatment for hepatocellular carcinoma]. Fabries P; Pauleau G; Brardjanian S; Artéaga C; Guisset M; Coton T Presse Med; 2013 Feb; 42(2):235-7. PubMed ID: 22425476 [No Abstract] [Full Text] [Related]
36. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants]. Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024 [TBL] [Abstract][Full Text] [Related]
37. Extended use of sulodexide, apixaban, rivaroxaban and dabigatran in venous thromboembolism: indirect comparison of clinical trials. Tomkowski W; Kuca P; Bignamini AA; Andreozzi GM Int Angiol; 2017 Oct; 36(5):496-497. PubMed ID: 28641408 [No Abstract] [Full Text] [Related]
38. Antidotes to non-vitamin K oral anticoagulants: necessary or not? Proietti M; Lip GY Expert Opin Pharmacother; 2015; 16(11):1573-6. PubMed ID: 26077323 [TBL] [Abstract][Full Text] [Related]
39. Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism. Howe Z; Naville-Cook C; Cole D J Thromb Thrombolysis; 2019 Feb; 47(2):280-286. PubMed ID: 30449001 [TBL] [Abstract][Full Text] [Related]